Cargando…
Precision medicine: The future of diagnostic approach to pulmonary hypertension?
Pulmonary hypertension (PH) is a common finding that can result from many different pathological conditions. Depending on the etiology, treatment may be quite different, but early diagnosis and correct classification of PH is difficult. With an aging population and recently suggested decreased pulmo...
Autores principales: | Kedzierski, Piotr, Torbicki, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955078/ https://www.ncbi.nlm.nih.gov/pubmed/31584446 http://dx.doi.org/10.14744/AnatolJCardiol.2019.97820 |
Ejemplares similares
-
Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022) -
Pulmonary Hypertension: Diagnosis and Management
por: Torbicki, Adam
Publicado: (2021) -
The pathophysiology of chronic thromboembolic pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2017) -
Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021) -
Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)